Evaluation and Management of Hyponatremia: An Emerging Role for Vasopressin Receptor Antagonists

Nature Clinical Practice Nephrology
doi 10.1038/ncpneph0450
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Role of Vasopressin Antagonists

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

The Vasopressin V2 Receptor Antagonists: The Vaptans

Global Journal of Endocrinological Metabolism
2018English

Azetidinones as Vasopressin V1a Antagonists

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2007English

Hyponatremia in Rats Induces Downregulation of Vasopressin Synthesis.

Journal of Clinical Investigation
Medicine
1990English

Caution in Correcting Hyponatremia in Patients on Vasopressin

Kansas Journal of Medicine
2011English

An Emerging Role for Agmatine

Kidney International
Nephrology
1999English

Evolving Role of Neurokinin 1-Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting

OncoTargets and Therapy
OncologyPharmacology
2018English

Discovery and Pharmacological Evaluation of Growth Hormone Secretagogue Receptor Antagonists

English

An Emerging Role for Chemical Biology

Nature Chemical Biology
Cell BiologyMolecular Biology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy